12:00 AM
Dec 17, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Merrimack preclinical data

In mouse models of breast cancer, tumor deposition of MM-DX-929 was significantly correlated with treatment response to MM-302 as measured by tumor volume changes on MRI over a 2-month period (p=0.0004)....

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >